In a latest review, we claimed the identification and also the characterization of a different atypical opioid receptor with exceptional adverse regulatory Houses in the direction of opioid peptides.one Our benefits showed that ACKR3/CXCR7, hitherto often known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is also a broad-spec